Ruiz-Alcaraz AJ, Baquero L, Pérez-Munar PM, Oliva-Bolarín A, Sánchez-Martínez MA, Ramos-Molina B, Núñez-Sánchez MA, Moreno DA. 2024. In Vitro Study of the Differential Anti-Inflammatory Activity of Dietary Phytochemicals upon Human Macrophage-like Cells as a Previous Step for Dietary Intervention. Int J Mol Sci. doi: 10.3390/ijms251910728 | PMID: 39409057

Núñez-Sánchez MÁ, Martínez-Sánchez MA (CFA), Sierra-Cruz M, Rico-Chazarra S, Oliva-Bolarín A, Balaguer-Román A, Yuste JE, Martínez CM, Mika A, Frutos MD, Llamoza-Torres CJ, Córdoba-Chacón J, Ramos-Molina B (CA). 2024. Increased hepatic putrescine levels as a new potential factor related to the progression of metabolic dysfunction-associated steatotic liver disease. J Pathol. doi: 10.1002/path.6330 | PMID: 39022853

Ramos-Molina B, Rossell J, Pérez-Montes de Oca A, Pardina E, Genua I, Rojo-López MI, Julián MT, Alonso N, Julve J, Mauricio D. 2024. Therapeutic implications for sphingolipid metabolism in metabolic dysfunction-associated steatohepatitis. Front Endocrinol (Lausanne). doi: 10.3389/fendo.2024.1400961 | PMID: 38962680

Martínez-Montoro JI, Martínez-Sánchez MA, Balaguer-Román A, Fernández-Ruiz VE, Hernández-Barceló JE, Ferrer-Gómez M, Frutos MD, Núñez-Sánchez MÁ, Fernández-García JC, Ramos-Molina B (CA). 2024. Triglyceride to HDL Cholesterol Ratio for the Identification of MASLD in Obesity: A Liver Biopsy-Based Case-Control Study. Nutrients. doi: 10.3390/nu16091310 | PMID: 38732557

Pérez-Díaz AJ, Núñez-Sánchez MÁ, Ramos-Molina B (CA). 2024. Revisiting liver metabolism through acetyl-CoA carboxylase inhibition. Trends Endocrinol Metab. doi: 10.1016/j.tem.2024.04.010 | PMID: 38664153

Castellano-Castillo D, Ramos-Molina B (CFA), Frutos MD, Arranz-Salas I, Reyes-Engel A, Queipo-Ortuño MI, Cardona F. 2024. RNA expression changes driven by altered epigenetics status related to NASH etiology. Biomed Pharmacother. doi: 10.1016/j.biopha.2024.116508 | PMID: 38579398

Núñez-Sánchez MA, Martínez-Sánchez MA (CFA), Martínez-Montoro JI, Balaguer-Román A, et al., Mika A, Ramos-Molina B (CA). 2024. Lipidomic analysis reveals alterations in hepatic FA profile associated with MASLD stage in patients with obesity. J Clin Endocrinol Metab. doi: 10.1210/clinem/dgae028 | PMID: 38217869

Colosimo S, Martínez-Sánchez MA, Balaguer-Román A, Fernández-Ruiz VE, Núñez-Sánchez MA, et al., Marchesini G, Ramos-Molina B. 2023. A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: a pilot study. Nutr Metab Cardiovasc Dis. doi: 10.1016/j.numecd.2023.12.008 | PMID: 38220504

Marsal-Beltran A, Rodríguez-Castellano A, et al., Ramos-Molina B, Aspichueta P, Joven J, Fernández-Real JM, Quer JC, Valverde ÁM, Pardo A, Vendrell J, Ceperuelo-Mallafré V, Fernández-Veledo S. 2023. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLD. Metabolism. doi: 10.1016/j.metabol.2023.155630 | PMID: 37315889

Zheng K, Hao F, Medrano-Garcia S, et al., Ramos Molina B, Herranz JM, Ávila MA, Nevzorova YA, Fernández-Malavé E, Cubero FJ. 2023. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis. Cell Death Dis. doi: 10.1038/s41419-023-06029-y | PMID: 37563155

Talamantes S, Lisjak M, Gilglioni EH, Llamoza-Torres CJ, Ramos-Molina B, Gurzov EN. 2023. Non-alcoholic fatty liver disease and diabetes mellitus as growing aetiologies of hepatocellular carcinoma. JHEP Reports. doi: 10.1016/j.jhepr.2023.100811 | PMID: 37575883

Babiy B, Ramos-Molina B (CFA), Ocaña L, et al., Pastor O. 2023. Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease. BBA Mol Cell Biol Lipids. doi: 10.1016/j.bbalip.2023.159318 | PMID: 37059386

Martinez-Montoro JI, Núñez-Sánchez MA (CFA), Martinez-Sánchez MA, et al., Fernandez-Garcia JC, Mika A, Ramos-Molina B. 2023. Hepatic and serum branched-chain fatty acid profile in patients with nonalcoholic fatty liver disease: A case-control study. Obesity (Silver Spring). doi: 10.1002/oby.23711 | PMID: 36981620

Martinez-Sánchez MA, Balaguer-Román A, Fernandez-Ruiz V, et al., Ruiz-Alcaraz AJ, Núñez-Sánchez MA (CA), Ramos-Molina B. 2023. Plasma short-chain fatty acid changes after bariatric surgery in patients with severe obesity. Surg Obes Relat Dis. doi: 10.1016/j.soard.2022.12.041 | PMID: 36842931

Lee SM, Muratalla J, Karimi S, Diaz-Ruiz A, Frutos MD, Guzman G, Ramos-Molina B, Cordoba-Chacon J. 2023. Hepatocyte PPARγ contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice. Cell Mol Life Sci. doi: 10.1007/s00018-022-04629-z | PMID: 36629912

Coppola I, Brouwers B, Walker L, Alar C, Meulemans S, White A, Ramos-Molina B (CA), Creemers JWM. 2022. Loss of hypothalamic Furin affects POMC to proACTH cleavage and feeding behavior in high-fat diet-fed mice. Mol Metab. doi: 10.1016/j.molmet.2022.101627 | PMID: 36374777

Núñez-Sánchez MA, Herisson FM, et al., Caplice NM, Gahan CGM. 2022. Microbial bile salt hydrolase activity influences gene expression profiles and gastrointestinal maturation in infant mice. Gut Microbes. doi: 10.1080/19490976.2022.2149023 | PMID: 36420990

Kuchay MS, Martínez-Montoro JI, Llamoza-Torres CJ, Fernández-García JC, Ramos-Molina B (CA). 2022. Liver cirrhosis and sarcopenia: a dreadful combination. Hepatobiliary Surg Nutr. doi: 10.21037/hbsn-22-355 | PMID: 36268240

Fernández-García JC, Barrios-Rodríguez R, Asenjo-Plaza M, Ramos-Molina B, et al., Martínez-González MÁ, Jiménez-Moleón JJ, Tinahones FJ. 2022. Metformin, testosterone, or both in men with obesity and low testosterone: A double-blind, parallel-group, randomized controlled trial. Metabolism. doi: 10.1016/j.metabol.2022.155290 | PMID: 35985506

Kuchay MS, Martínez-Montoro JI, Kaur P, Fernández-García JC, Ramos-Molina B (CA). 2022. Non-alcoholic fatty liver disease-related fibrosis and sarcopenia: An altered liver-muscle crosstalk leading to increased mortality risk. Ageing Res Rev. doi: 10.1016/j.arr.2022.10169 | PMID: 35843589

Martínez-Montoro JI, Kuchay MS, et al., Fernández-García JC, Ramos-Molina B (CA). 2021. Gut Microbiota and Related Metabolites in the Pathogenesis of Non-Alcoholic Steatohepatitis and its Resolution after Bariatric Surgery. Obesity Reviews. doi: 10.1111/obr.13367 | PMID: 34729904

Brouwers B, Coppola I, Vints K, et al., Ramos-Molina B (CA), Creemers JW. 2021. Loss of Furin in β cells induces an mTORC1-ATF4 anabolic pathway that leads to β cell dysfunction. Diabetes. 2020 Dec 4:db200474. doi: 10.2337/db20-0474 | PMID: 33277337